David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Intercontinental Exchange
ICE
$90.5B
| $85.3M | 0.15% |
1,814,855
+318,660
| +21% | +$15.5M |
|
|
PARA
152
DELISTED
Paramount Global Class B
PARA
| $85.2M | 0.15% |
1,546,619
-1,097,432
| -42% | -$53.4M |
|
|
MRO
153
DELISTED
Marathon Oil Corporation
MRO
| $84.7M | 0.15% |
7,603,381
+5,233,925
| +221% | +$48.9M |
|
|
LBRDA
154
DELISTED
Liberty Broadband Class A
LBRDA
| $84.6M | 0.15% |
1,454,793
-10,524
| -0.7% | -$531K |
|
155
Amdocs
DOX
$6.41B
| $83.8M | 0.15% |
1,387,360
+72,004
| +5% | +$4.03M |
|
156
CALL
Walt Disney
DIS
$186B
| $83.8M | 0.15% |
843,800
+449,600
| +114% | +$43.4M |
|
|
VMW
157
DELISTED
VMware, Inc
VMW
| $82.8M | 0.15% |
1,582,929
+1,032,814
| +188% | +$51.2M |
|
158
Mondelez International
MDLZ
$82.3B
| $81.8M | 0.15% |
2,037,839
+1,114,452
| +121% | +$45.4M |
|
159
Sabre
SABR
$848M
| $81M | 0.15% |
2,801,173
+769,454
| +38% | +$20.5M |
|
|
FCAM
160
DELISTED
Fiat Chrysler Automobiles N.V.
FCAM
| $80.7M | 0.14% |
1,115,000
+100,000
| +10% | +$6.66M |
|
161
Armstrong World Industries
AWI
$7.55B
| $80.4M | 0.14% |
1,661,412
-729,578
| -31% | -$29.9M |
|
|
LTRPA
162
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $79.2M | 0.14% |
3,574,592
+670,341
| +23% | +$14.7M |
|
163
Genpact
G
$6.24B
| $78.8M | 0.14% |
2,896,695
+1,169,386
| +68% | +$29.6M |
|
|
TMUSP
164
DELISTED
T-Mobile US, Inc.5.50% Mandatory Convertible Preferred Stock, Series A
TMUSP
| $78.6M | 0.14% |
1,189,500
+254,500
| +27% | +$16.6M |
|
|
WOOF
165
DELISTED
VCA Inc.
WOOF
| $78.4M | 0.14% |
1,358,502
+119,242
| +10% | +$6.18M |
|
166
IBM
IBM
$222B
| $77.5M | 0.14% |
534,955
+229,372
| +75% | +$29.3M |
|
167
Abbott
ABT
$202B
| $77.4M | 0.14% |
1,850,683
+265,357
| +17% | +$10.5M |
|
|
EVHC
168
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $77.3M | 0.14% |
1,266,092
-346,734
| -21% | -$22.8M |
|
169
PUT
Chevron
CVX
$403B
| $75.4M | 0.14% |
790,200
-107,300
| -12% | -$9.39M |
|
170
Constellation Brands
STZ
$23.2B
| $74.9M | 0.13% |
495,794
-676,185
| -58% | -$97.7M |
|
171
Delek US
DK
$4.38B
| $74.7M | 0.13% |
4,898,815
-416,679
| -8% | -$6.72M |
|
172
Pitney Bowes
PBI
$2.26B
| $74.3M | 0.13% |
3,449,183
-45,378
| -1% | -$862K |
|
|
173
CALL
Chevron
CVX
$403B
| $73.5M | 0.13% |
770,800
-368,300
| -32% | -$32.2M |
|
|
MON
174
DELISTED
Monsanto Co
MON
| $72.8M | 0.13% |
830,038
-427,431
| -34% | -$38.6M |
|
175
PUT
Tesla
TSLA
$1.43T
| $72.8M | 0.13% |
4,750,500
+3,406,500
| +253% | +$44.8M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.